Tilray Receives Approval for International Medical Cannabis Export

Tilray (NASDAQ:TLRY) confirmed that its wholly-owned subsidiary, Tilray Portugal, has received its Good Manufacturing Practice (GMP) certification in accordance with European Union standards for its manufacturing facility in Cantanhede, Portugal.

As quoted in the press release:

The GMP certification was issued by Infarmed, the Portuguese National Authority of Medicines and Health Products. This is the second GMP certification for Tilray Portugal, which allows the facility to manufacture and export GMP-certified finished medical cannabis products, including dried flower and oils, from Portugal to international markets with legal medical cannabis regulations.

“We are pleased with the continued momentum of our growth strategy across Europe with this additional GMP certification for Tilray’s EU campus in Portugal,” says Brendan Kennedy, Tilray CEO. “This will enable us to export a greater range of medical products to international patients, partners and markets. Our international strategy is an important component in driving profitability and long-term shareholder value.”

Click here to read the full press release.